Epilepsy Research
Volume 31, Issue 1 , Pages 47-57 , June 1998

Gabapentin and carbamazepine affect eye movements and posture control differently: A placebo-controlled investigation of acute CNS side effects in healthy volunteers

Received 30 October 1997 ,Revised 27 February 1998 ,Accepted 1 March 1998.

References 

  1. Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia. 1979;20:729–737
  2. Bittencourt PR, Gresty MA, Richens A. Quantitative assessment of smooth-pursuit eye movements in healthy and epileptic subjects. J. Neurol. Neurosurg. Psychiatry. 1980;43:1119–1124
  3. Brandt, T., 1991. Vertigo: Its Multisensory Syndromes. Springer, London.
  4. Buttner U, Grundei T. Gaze evoked nystagmus and smooth pursuit deficits: their relationship studied in 52 patients. J. Neurol. 1995;242:384–389
  5. Cohen AF, Ashby L, Crowly D, Land G, Peck AW, Miller AA. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br. J. Clin. Pharmacol. 1985;20:619–629
  6. Collaborative Group for Epidemiology of Epilepsy . Adverse reactions to antiepileptic drugs a multicenter survey of clinical practice. Epilepsia. 1986;27:323–330
  7. Dieterich M, Straube A, Brandt T, Paulus W, Büttner U. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J. Neurol. Neurosurg. Psychiatry. 1991;54:627–632
  8. Ditterich, J., 1995. Untersuchung in die Sakkadensteuerung involvierter Gehirnstrukturen mittles Computertools. Thesis, University of Munich.
  9. Elwes RDC, Johnson AL, Shorvon SD, Reynolds EH. The prognosis for seizure control in newly diagnosed epilepsy. New Engl. J. Med. 1984;311:944–947
  10. Hamilton MJ, Cohen AF, Zuen AWC, Harkin N, Land G, Weatherley BC, et al. Carbamazepine and lamotrigine in healthy volunteers: relevance of early tolerance and clinical trial dosage. Epilepsia. 1993;34:166–173
  11. Hepp K, Henn V. Spatio-temporal recording of rapid eye movement signals in the monkey paramedian pontine reticular formation (PPRF). Exp. Brain Res. 1983;52:105–120
  12. Hermsdörfer J, Mai N. Disturbed grip-force control following cerebral lesions. J. Hand Ther. 1996;9:33–40
  13. Holmes, G.L., 1995. Carbamazepine: toxicity. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs. Raven Press, New York, pp. 567–579.
  14. Leigh, R.J., Zee, D., 1991. The Neurology of Eye Movement. Davis, Philadelphia.
  15. Lempert, T., Ried, S., Schmidt, D., 1990. Addition of vigabatrin has no effect on eye movements and posture control. In: Brandt, T., Paulus, W., Bles, W., Dieterich, M., Krafczyk, S., Straube, A. (Eds.), Disorders of Posture and Gait. Thieme, Stuttgart, pp. 358–360.
  16. Lesser RP, Pippenger CE, Luders H, Dinner DS. High-dose monotherapy in treatment of intractable seizures. Neurology. 1984;34:707–711
  17. Murray, G., Anhut, H., Greiner, M.J., Alexander, J., Chadwick, D., The International GBP Monotherapie Study Group 945-77/78, 1997. Gabapentin (neurontin) monotherapy: Results of a multicenter study comparing gabapentin and carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsia 38, 205.
  18. Paulus WM, Straube A, Brandt T. Visual stabilization of posture. Physiological stimulus characteristics and clinical aspects. Brain. 1984;107:1143–1163
  19. Ramsay RE. Clinical efficacy and safety of gabapentin. Neurology. 1994;44:S23–30
  20. Remler BF, Leigh RJ, Osorio I, Tomsak RL. The characteristics and mechanisms of visual disturbance associated with anticonvulsant therapy. Neurology. 1990;40:791–796
  21. Specht U, May TW, Rhode M, Wagner V, Schmidt RC, Schütz M. Carbamazepine toxicity in focal epilepsy with and without cerebellar atrophy. Epilepsia. 1994;35:114
  22. Stahl JS, Rottach KG, Averbuch-Heller L, von Maydell RD, Collins SD, Leigh RJ. A pilot study of gabapentin as treatment for acquired nystagmus. Neuro-Ophthalmology. 1996;16:107–113
  23. Taylor, C.P., 1995. Gabapentin: Mechanisms of action. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs. Raven Press, New York, pp. 829–841.
  24. Tedeschi G, Casucci G, Allocca S, et al.  Neuroocular side effects of carbamazepine and phenobarbital in epileptic patients as measured by saccadic eye movements analysis. Epilepsia. 1989;30:62–66
  25. Umeda Y, Sakata E. Equilibrium disorder in carbamazepine toxicity. Ann. Otol. Rhinol. Laryngol. 1977;86:318–322
  26. Welty DF, Schielke GP, Vartanian MG, Taylor CP. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Res. 1993;16:175–181
  27. Wheeler SD, Ramsay RE, Weiss J. Drug-induced downbeat nystagmus. Ann. Neurol. 1982;12:227–228

PII: S0920-1211(98)00015-1

Epilepsy Research
Volume 31, Issue 1 , Pages 47-57 , June 1998

Article Tools

* Image Usage & Resolution